Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Gamida Cell $60 million follow-on offering

Davis Polk advised the representatives of the underwriters in connection with the $60 million SEC-registered follow-on offering of ordinary shares of Gamida Cell Ltd. The ordinary…

Lockheed Martin $1.15 billion notes offering

Davis Polk advised the underwriters in connection with the offering of $1.15 billion aggregate principal amount of notes issued by Lockheed Martin Corporation. The notes were offered in two…

ADC Therapeutics $267 million IPO

Davis Polk advised ADC Therapeutics SA on its SEC-registered initial public offering of 14,082,475 common shares, which included the exercise in full by the underwriters of their option to…
Back to top